Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma.

Cui X, Zhao J, Li G, Yang C, Yang S, Zhan Q, Zhou J, Wang Y, Xiao M, Hong B, Yi K, Tong F, Tan Y, Wang H, Wang Q, Jiang T, Fang C, Kang C

Open source

DOI: 10.1002/cac2.12502
Published: 2023 Dec
Container: Cancer communications (London, England)
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cac2.12502,
  title = {Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma.},
  author = {Cui X and Zhao J and Li G and Yang C and Yang S and Zhan Q and Zhou J and Wang Y and Xiao M and Hong B and Yi K and Tong F and Tan Y and Wang H and Wang Q and Jiang T and Fang C and Kang C},
  year = {2023},
  journal = {Cancer communications (London, England)},
  doi = {10.1002/cac2.12502},
  url = {https://doi.org/10.1002/cac2.12502}
}

RIS

TY  - JOUR
TI  - Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma.
AU  - Cui X
AU  - Zhao J
AU  - Li G
AU  - Yang C
AU  - Yang S
AU  - Zhan Q
AU  - Zhou J
AU  - Wang Y
AU  - Xiao M
AU  - Hong B
AU  - Yi K
AU  - Tong F
AU  - Tan Y
AU  - Wang H
AU  - Wang Q
AU  - Jiang T
AU  - Fang C
AU  - Kang C
PY  - 2023
JO  - Cancer communications (London, England)
DO  - 10.1002/cac2.12502
UR  - https://doi.org/10.1002/cac2.12502
ER  -

APA

X, C., J, Z., G, L., C, Y., S, Y., Q, Z., J, Z., Y, W., M, X., B, H., K, Y., F, T., Y, T., H, W., Q, W., T, J., C, F., & C, K. (2023). Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma.. Cancer communications (London, England). https://doi.org/10.1002/cac2.12502

Source records

pubmed · retrieved 2026-09-25T16:26:47.096Z
europe-pmc · retrieved 2026-09-25T16:26:47.119Z
doaj · retrieved 2026-09-25T16:26:47.093Z